In vivo recording of suprachiasmatic nucleus dynamics reveals a dominant role of arginine vasopressin neurons in circadian pacesetting

PLoS Biol. 2023 Aug 29;21(8):e3002281. doi: 10.1371/journal.pbio.3002281. eCollection 2023 Aug.

Abstract

The central circadian clock of the suprachiasmatic nucleus (SCN) is a network consisting of various types of neurons and glial cells. Individual cells have the autonomous molecular machinery of a cellular clock, but their intrinsic periods vary considerably. Here, we show that arginine vasopressin (AVP) neurons set the ensemble period of the SCN network in vivo to control the circadian behavior rhythm. Artificial lengthening of cellular periods by deleting casein kinase 1 delta (CK1δ) in the whole SCN lengthened the free-running period of behavior rhythm to an extent similar to CK1δ deletion specific to AVP neurons. However, in SCN slices, PER2::LUC reporter rhythms of these mice only partially and transiently recapitulated the period lengthening, showing a dissociation between the SCN shell and core with a period instability in the shell. In contrast, in vivo calcium rhythms of both AVP and vasoactive intestinal peptide (VIP) neurons in the SCN of freely moving mice demonstrated stably lengthened periods similar to the behavioral rhythm upon AVP neuron-specific CK1δ deletion, without changing the phase relationships between each other. Furthermore, optogenetic activation of AVP neurons acutely induced calcium increase in VIP neurons in vivo. These results indicate that AVP neurons regulate other SCN neurons, such as VIP neurons, in vivo and thus act as a primary determinant of the SCN ensemble period.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine Vasopressin*
  • Calcium*
  • Mice
  • Neuroglia
  • Neurons
  • Suprachiasmatic Nucleus
  • Vasoactive Intestinal Peptide

Substances

  • Arginine Vasopressin
  • Calcium
  • Vasoactive Intestinal Peptide

Grants and funding

This work was supported in part by JSPS KAKENHI Grant Numbers JP20K07259, JP23K06345 (to Y.T.); JP22K20738 (to A.M.); JP18H04972, JP18K19421, JP20K21498, JP22H02802 (to M.M.) (Japan Society for the Promotion of Science: https://www.jsps.go.jp/english/index.html); JST SPRING Grant Number JPMJSP2135 (to Y.P., M.W.) (Japan Science and Technology Agency: https://www.jst.go.jp/EN/); the Takeda Science Foundation (to M.M.) (https://www.takeda-sci.or.jp/en/); the Naito Foundation (to M.M.) (https://www.naito-f.or.jp/en/); the Japan Foundation for Applied Enzymology (to M.M.) (https://www.jfae.or.jp/); and Kanazawa University CHOZEN project (to M.M.) (http://www.o-fsi.kanazawa-u.ac.jp/research/chozen/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.